These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34893769)
1. The race to make vaccines for a dangerous respiratory virus. Powell K Nature; 2021 Dec; 600(7889):379-380. PubMed ID: 34893769 [No Abstract] [Full Text] [Related]
4. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein. Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590 [TBL] [Abstract][Full Text] [Related]
5. Passive and active immunization against respiratory syncytial virus for the young and old. Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961 [TBL] [Abstract][Full Text] [Related]
6. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease. Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586 [TBL] [Abstract][Full Text] [Related]
7. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection. Liang B; Munir S; Amaro-Carambot E; Surman S; Mackow N; Yang L; Buchholz UJ; Collins PL; Schaap-Nutt A J Virol; 2014 Apr; 88(8):4237-50. PubMed ID: 24478424 [TBL] [Abstract][Full Text] [Related]
8. van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038 [TBL] [Abstract][Full Text] [Related]
9. RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths. Abbasi J JAMA; 2022 Jan; 327(3):204-206. PubMed ID: 34964806 [No Abstract] [Full Text] [Related]
10. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses. Palomo C; Mas V; Thom M; Vázquez M; Cano O; Terrón MC; Luque D; Taylor G; Melero JA J Virol; 2016 Jun; 90(11):5485-5498. PubMed ID: 27009962 [TBL] [Abstract][Full Text] [Related]
11. A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity. Murakami K; Matsuura M; Ota M; Gomi Y; Yamanishi K; Mori Y Vaccine; 2015 Nov; 33(45):6085-92. PubMed ID: 26116253 [TBL] [Abstract][Full Text] [Related]
12. A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV. Turner TM; Jones LP; Tompkins SM; Tripp RA J Virol; 2013 Oct; 87(19):10792-804. PubMed ID: 23903841 [TBL] [Abstract][Full Text] [Related]
13. Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice. Rey GU; Miao C; Caidi H; Trivedi SU; Harcourt JL; Tripp RA; Anderson LJ; Haynes LM PLoS One; 2013; 8(12):e83075. PubMed ID: 24376637 [TBL] [Abstract][Full Text] [Related]
14. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Crowe JE Clin Infect Dis; 2001 Nov; 33(10):1720-7. PubMed ID: 11595986 [TBL] [Abstract][Full Text] [Related]